首页> 外国专利> Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease

Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease

机译:激活或阻断HLA-E / Qa-1限制性CD8 + T细胞调节途径来治疗免疫疾病的方法

摘要

Methods are provided for inhibiting or enhancing down-regulation of an antigen-activated HLA-E+ T cell by an HLA-E-restricted CD8+ T cell comprising contacting the HLA-E+ T cell and CD8+ T cell with an agent which inhibits or enhances, respectively, binding between (i) T cell receptor (TCR) on the surface of the CD8+ T cell and (ii) a self peptide presented by HLA-E on the surface of the HLA-E+ T cell, thereby inhibiting or enhancing, respectively, down-regulation of the antigen-activated HLA-E+ T cell. Compositions comprising agents which inhibit or enhance/activate, respectively, binding between (i) T cell receptor (TCR) on the surface of a CD8+ T cell and (ii) a self peptide presented by HLA-E on the surface of a HLA-E+ T cell, and assays for identifying such agents, are provided.
机译:提供了通过HLA-E限制性CD8 + T细胞抑制或增强抗原激活的HLA-E + T细胞下调的方法,包括与HLA接触-E + T细胞和CD8 + T细胞,分别带有抑制或增强(i)T细胞受体(TCR)表面上的结合的试剂CD8 + T细胞和(ii)HLA-E在HLA-E + T细胞表面呈现的自身肽,从而分别抑制或增强抗原激活的HLA-E + T细胞的调控包含分别抑制或增强/激活(i)CD8 + T细胞表面上的T细胞受体(TCR)与(ii)HLA-呈递的自身肽之间结合的试剂的组合物提供了在HLA-E + T细胞表面的E,并鉴定了这些试剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号